These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14740074)

  • 41. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 43. [Physical activity and atherosclerosis: effect of dynamic activity of various intensity on parameters of lipid-transport system and carbohydrate metabolism in patients with coronary heart disease and type 2 diabetes].
    Bubnova MG; Aronov DM; Perova NV; Zvolinskaia EIu
    Kardiologiia; 2005; 45(11):32-8. PubMed ID: 16353062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelets and Antiplatelet Therapy in Patients with Coronary Artery Disease and Diabetes.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL
    Semin Thromb Hemost; 2016 Apr; 42(3):234-41. PubMed ID: 26886397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 47. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of the metabolic syndrome in children.
    Steinberger J
    Curr Opin Lipidol; 2003 Dec; 14(6):555-9. PubMed ID: 14624131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of the patient with diabetes and coronary artery disease: a contemporary review.
    Raymond T; Raymond R; Lincoff AM
    Future Cardiol; 2013 May; 9(3):387-403. PubMed ID: 23668743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of in-utero undernutrition on the insulin resistance syndrome.
    Jaquet D; Leger J; Czernichow P; Levy-Marchal C
    Curr Diab Rep; 2002 Feb; 2(1):77-82. PubMed ID: 12643126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D; Krone W
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.
    Reusch JE
    Am J Cardiol; 2002 Sep; 90(5A):19G-26G. PubMed ID: 12231075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [THE INFLUENCE OF MONO- AND MULTIVASCULAR LESIONS OF CORONARY ARTERIES ON THE COURSE OF CORONARY HEART DISEASE IN PATIENTS WITH DIABETES MELLITUS TYPE 2].
    Sypalo A; Kravchun P; Kadykova O
    Georgian Med News; 2017 Mar; (264):61-65. PubMed ID: 28480852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines.
    Emamalipour M; Seidi K; Jahanban-Esfahlan A; Jahanban-Esfahlan R
    J Cell Physiol; 2019 Dec; 234(12):21758-21769. PubMed ID: 31187484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Insulin resistance and its involvement in multiple risk factors associated with type 2 diabetes mellitus].
    Serrano Rios M; Ascaso Gimilio JF; Blázquez Fernández E; Cabezas Cerraro J; Carmena Rodríguez R; Escobar Jiménez F; Fernández-Real JM; Gabriel Sánchez R; Gomis de Barberá R; Grande Aragón C; Herrera Pomba JL; Pallardo Sánchez LF; Potau Vilalta N; Ricart Engel W; Rovira Loscos A; Zorzano Olarte A;
    Med Clin (Barc); 2002 Oct; 119(12):458-63. PubMed ID: 12385655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.